Gapping up
In reaction to earnings/guidance:
- CAMT +5.3%, AZZ +4.3%, GOL +0.9%
Other news:
- GNS +16.5% (acquires California based University of Antelope Valley)
- DWAC +16.2% (moves +11% higher after hours after Elon Musk backs out of Twitter deal)
- HITI +5.9% (High Tide's Blessed CBD has begun sales of its premium hemp-derived CBD products on Amazon in the United Kingdom)
- TKR +5% (selected as exclusive provider of advanced precision drives for the Redstone Solar Thermal Power project in Northern Cape, South Africa)
- EURN +2.5% (Frontline considers takeover bid on Euronav NV (EURN))
- IONS +2.3% (licenses rare kidney disease treatment and will advance into Phase 3 clinical study)
- PRGO +2.1% (submitted its application to the FDA for the first-ever over-the-counter (OTC) birth control pill in the United States)
- PODD +1.9% (entered into a settlement and license agreement with Roche (RHHBY) Diabetes Care)
Analyst comments:
- APG +2.5% (upgraded to Buy from Neutral at BofA Securities)